Free tool
FAERS Monitor: Forane
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 017624 or its brand name (Forane, Isoflurane). Reports on generic versions are filed under their own applications.
Reports
1,965
Serious
1,845
94% of reports
Hospitalization
764
Death reported
299
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- hypotension238
- drug ineffective181
- renal failure158
- pain149
- injury136
- drug interaction129
- anxiety128
- unevaluable event123
- off label use115
- hyperthermia malignant114
- fear110
- emotional distress103
- renal injury99
- death98
- metabolic acidosis97
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 79 |
| 2005 | 67 |
| 2006 | 55 |
| 2007 | 68 |
| 2008 | 98 |
| 2009 | 69 |
| 2010 | 88 |
| 2011 | 245 |
| 2012 | 76 |
| 2013 | 78 |
| 2014 | 57 |
| 2015 | 85 |
| 2016 | 83 |
| 2017 | 86 |
| 2018 | 89 |
| 2019 | 95 |
| 2020 | 104 |
| 2021 | 94 |
| 2022 | 58 |
| 2023 | 82 |
| 2024 | 56 |
| 2025 | 75 |
| 2026 | 74 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,194 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| hyperthermia malignantSignal | 114 | 888.3 | 737.6 | 92,487 |
| fearSignal | 110 | 44.0 | 36.6 | 4,562 |
| renal injurySignal | 99 | 35.8 | 29.5 | 3,306 |
| metabolic acidosisSignal | 97 | 32.6 | 26.8 | 2,932 |
| injurySignal | 136 | 20.7 | 17.6 | 2,540 |
| unevaluable eventSignal | 123 | 17.4 | 14.7 | 1,892 |
| renal failureSignal | 158 | 12.7 | 11.0 | 1,708 |
| hypotensionSignal | 238 | 12.7 | 11.3 | 2,578 |
| emotional distressSignal | 103 | 9.1 | 7.6 | 740 |
| drug interactionSignal | 129 | 8.7 | 7.4 | 879 |
| anxietySignal | 128 | 4.8 | 4.1 | 388 |
| painSignal | 149 | 2.6 | 2.2 | 149 |
| drug ineffective | 181 | 1.5 | 1.3 | 29 |
| off label use | 115 | 1.4 | 1.2 | 14 |
| death | 98 | 1.2 | 1.0 | 4 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.